85 related articles for article (PubMed ID: 28741673)
1. Eslicarbazepine acetate as adjunctive treatment in partial-onset epilepsy.
Lattanzi S; Cagnetti C; Foschi N; Lorusso A; Provinciali L; Silvestrini M
Acta Neurol Scand; 2018 Jan; 137(1):29-32. PubMed ID: 28741673
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of adjunctive eslicarbazepine acetate in adult Asian patients with refractory focal seizures: Post hoc analysis of a phase III trial.
Lee SK; Lee SA; Hong SB; Cho YW; Castilla-Fernández G; Fonseca MM; Moreira J; Gama H; Holenz J
Clin Transl Sci; 2024 May; 17(5):e13802. PubMed ID: 38787305
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of eslicarbazepine: current evidence.
Zaccara G; Giovannelli F; Cincotta M; Carelli A; Verrotti A
Drug Des Devel Ther; 2015; 9():781-9. PubMed ID: 25709402
[TBL] [Abstract][Full Text] [Related]
4. A Prospective Longitudinal Study of the Effects of Eslicarbazepine Acetate Treatment on Bone Density and Metabolism in Patients with Focal-Onset Epilepsy.
Hirsch M; Immisch I; Knake S; Schulze-Bonhage A
CNS Drugs; 2023 Nov; 37(11):973-980. PubMed ID: 37921919
[TBL] [Abstract][Full Text] [Related]
5. Eslicarbazepine acetate in the treatment of adults with partial-onset epilepsy: an evidence-based review of efficacy, safety and place in therapy.
Lattanzi S; Brigo F; Cagnetti C; Verrotti A; Zaccara G; Silvestrini M
Core Evid; 2018; 13():21-31. PubMed ID: 29563858
[TBL] [Abstract][Full Text] [Related]
6. Efficacy, safety, and tolerability of adjunctive eslicarbazepine acetate in patients with focal to bilateral tonic-clonic seizures.
Chung S; Guirguis S; Cantu D; Moreira J; Magalhães LM; Hall D; Grinnell T
Epilepsy Res; 2024 Feb; 200():107285. PubMed ID: 38183687
[TBL] [Abstract][Full Text] [Related]
7. Overnight switch from carbamazepine to eslicarbazepine in a real-life clinical scenario: a retrospective study.
Sancetta BM; Ricci L; Lanzone J; Boscarino M; Narducci F; Lippa G; Nesta M; Di Lazzaro V; Tombini M; Assenza G
Neurol Sci; 2024 Jul; 45(7):3435-3442. PubMed ID: 38315252
[TBL] [Abstract][Full Text] [Related]
8. Eslicarbazepine acetate (BIA 2-093).
Almeida L; Soares-da-Silva P
Neurotherapeutics; 2007 Jan; 4(1):88-96. PubMed ID: 17199020
[TBL] [Abstract][Full Text] [Related]
9. Thirteen years of experience with eslicarbazepine acetate in the United Kingdom and Republic of Ireland: A safety perspective.
Guedes L; Vieira M; Gama H; Magano D; Fernandes M; Calero P; Di Foggia V
Epileptic Disord; 2023 Dec; 25(6):803-814. PubMed ID: 37584596
[TBL] [Abstract][Full Text] [Related]
10. Antioxidants for female subfertility.
Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD007807. PubMed ID: 28752910
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: a Single-Center Prospective Trial.
Parta M; Kelly C; Kwatemaa N; Theobald N; Hilligoss D; Qin J; Kuhns DB; Zerbe C; Holland SM; Malech H; Kang EM
J Clin Immunol; 2017 Aug; 37(6):548-558. PubMed ID: 28752258
[TBL] [Abstract][Full Text] [Related]
12. Health care resource utilization before and after perampanel initiation among patients with epilepsy in the United States.
Faught E; Laliberté F; Wang Z; Barghout V; Haider B; Lejeune D; Germain G; Choi J; Wagh A; Duh MS
Epilepsia; 2017 Oct; 58(10):1742-1748. PubMed ID: 28741690
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for stomatitis in patients with lymphangioleiomyomatosis during treatment with sirolimus: A multicenter investigator-initiated prospective study.
Kitamura N; Seyama K; Inoue Y; Nagai K; Suzuki M; Moriyama H; Takada T; Tazawa R; Hirai T; Mishima M; Hayashida M; Hirose M; Arai T; Sugimoto C; Hattori N; Watanabe K; Tamada T; Akazawa K; Tanaka T; Nakata K
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1182-1189. PubMed ID: 28752672
[TBL] [Abstract][Full Text] [Related]
14. Long-term Outcomes of Paclitaxel-Eluting Versus Sirolimus-Eluting Stent for Percutaneous Coronary Intervention: AMeta-Analysis.
Kong J; Liu P; Fan X; Wen J; Zhang J; Zhen Y; Li J; Cui Y; Zheng X; Ye Z
J Coll Physicians Surg Pak; 2017 Jul; 27(7):432-439. PubMed ID: 28818167
[TBL] [Abstract][Full Text] [Related]
15. Superficial hemangioma is better treated by topical 5-aminolevulinic followed by 595-nm pulsed dye laser therapy rather than 595-nm laser therapy alone.
Zeng M; Shen S; Chen W; Yang C; Liu S
Lasers Med Sci; 2017 Nov; 32(8):1889-1893. PubMed ID: 28812167
[TBL] [Abstract][Full Text] [Related]
16. ACE inhibitor-associated intestinal angioedema in orthotopic heart transplantation.
Srinivasan D; Strohbehn GW; Cascino T
ESC Heart Fail; 2017 Aug; 4(3):384-386. PubMed ID: 28772029
[TBL] [Abstract][Full Text] [Related]
17. Use and safety of antiepileptic drugs in psychiatric inpatients-data from the AMSP study.
Druschky K; Bleich S; Grohmann R; Engel RR; Kleimann A; Stübner S; Greil W; Toto S
Eur Arch Psychiatry Clin Neurosci; 2018 Mar; 268(2):191-208. PubMed ID: 28766129
[TBL] [Abstract][Full Text] [Related]
18. Deriving vascular smooth muscle cells from mesenchymal stromal cells: Evolving differentiation strategies and current understanding of their mechanisms.
Zhang X; Bendeck MP; Simmons CA; Santerre JP
Biomaterials; 2017 Nov; 145():9-22. PubMed ID: 28843066
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus therapy in the treatment of pseudomyogenic hemangioendothelioma.
Gabor KM; Sapi Z; Tiszlavicz LG; Fige A; Bereczki C; Bartyik K
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28843050
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
